Casey Orvin currently serves as Honorary President of the Society for Clinical Research Sites (SCRS), a global organization representing over 9,500 clinical research sites in 47 countries within the pharmaceutical industry and the Chief Commercial Officer of CenExel Clinical Research, a clinical research site network specializing in inpatient and outpatient psychiatry, pain, and vaccines services.
A native of Conway, Casey graduated from the University of Central Arkansas (UCA) in 2001. He began his career in Little Rock at Research Solutions, a large pharmaceutical research site network.
In 2007, he was recruited to join Clinical Research Advantage/Radiant as Executive Vice President of Business Development and successfully led a network of over 75 research sites conducting clinical trials for pharmaceuticals, vaccines, and medical devices. Under his leadership, several crucial partnerships were formed with major pharmaceutical companies which fueled the company’s rapid growth both geographically and within the medical community. Casey facilitated the acquisition of two competitors securing the company’s spot as the largest clinical research site network in the US.
In 2015, Casey and the executive team at Radiant merged with the largest site network in the world, Synexus. Under his leadership, Synexus continued to expand into 4 continents and over 15 countries.
As a thought-leader in the industry, Casey is regularly sought after as a keynote speaker and panelist and is often quoted by the leading publications covering the clinical research landscape. In 2020, he was recognized in PharmaVoice as one of the 100 Most Inspiring People in the pharmaceutical industry.
Outside of the office, Casey is active in his church and community and considers his proudest accomplishments in life being a husband to his wonderful wife and father to his three amazing children.